
zzso The zzso zzso effects and zzso effects of intravenous zzso were studied in 20 cancer patients with zzso Four different dose levels zzso 1, 2, and 4 zzso 70 zzso were zzso Plasma zzso of zzso were measured for 12 h after zzso Pulse rate, respiratory rate and blood pressure were zzso and pain relief was measured using two rating scales and a visual analogue zzso zzso The mean elimination zzso zzso zzso of zzso was zzso zzso zzso zzso The mean zzso zzso to a dose of 1 zzso 70 zzso was 390 zzso 263 zzso zzso zzso Mean zzso clearance was 96 zzso 38 zzso zzso There was a direct relationship between zzso plasma clearance and calculated zzso clearance zzso zzso zzso P less than zzso 38 zzso zzso of the dose of zzso was recovered unchanged in the urine in 24 zzso No zzso or zzso was detected in the plasma or urine of any patient after zzso zzso zzso zzso exerted a useful zzso effect in zzso zzso patients for periods ranging between 2 and 24 zzso No correlation was observed between dose or plasma zzso zzso and duration or degree of zzso No clinically significant changes in zzso parameters were zzso No patients reported sedation or zzso zzso and vomiting were notably absent in all zzso zzso zzso is an effective and zzso zzso It is likely that the majority of the therapeutic benefit of zzso is zzso by zzso zzso AT 250 zzso 

